The role of immunometabolic pathways in atherosclerosis

免疫代谢途径在动脉粥样硬化中的作用

基本信息

  • 批准号:
    8967582
  • 负责人:
  • 金额:
    $ 40.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-11-15 至 2018-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Atherosclerosis and associated cardiovascular disease (CVD) are the leading cause of morbidity and mortality in the US. Atherosclerosis is characterized by the accumulation of lipids in the artery wall, and is an inflammatory disease in which several immune effectors including macrophages play a central role. Obesity, insulin resistance, diabetes, and dyslipidemia are all major risk factors for CVD, but the mechanisms that link disordered metabolism to inflammation and the development of atherosclerosis remain to be elucidated. Our published work and preliminary data demonstrate that the double stranded RNA activated protein kinase, PKR, is activated in the context of obesity, where it plays a critica role in driving inflammation and the deterioration of glucose homeostasis. In macrophages, exposure to lipotoxic signals and lipoproteins activate PKR. In addition, PKR is a critical component for the activation of the NLRP3 inflammasome, and stress signaling pathways such as JNK, which are implicated in the pathogenesis of both diabetes and atherosclerosis. In addition, in supporting data presented in this proposal we demonstrate a significant protection against atherosclerotic plaque development in PKR-deficient mice. Based on these findings our overarching hypothesis is that by modulating inflammatory activity, insulin action, and protein synthesis, PKR links cellular stress and metabolic signals to chronic inflammation and atherosclerosis. The experiments described in this proposal will test that hypothesis by determining the role of PKR in the activation and function of macrophages, and by assessing the whole body and macrophage-specific requirement for PKR in the development of atherosclerosis in vivo. This contribution will expand our understanding of the link between nutrient stress and the development of cardiometabolic disease. The innovation of this work lies in investigating a novel approach to atherosclerosis therapy by identifying the mechanistic link between dyslipidemia and inflammatory activation of immune cells.
描述(由申请人提供):动脉粥样硬化和相关心血管疾病(CVD)是美国发病和死亡的主要原因。动脉粥样硬化的特征是动脉壁中脂质积聚,是一种炎症性疾病,其中包括巨噬细胞在内的多种免疫效应物发挥核心作用。肥胖、胰岛素抵抗、糖尿病和血脂异常都是CVD的主要危险因素,但代谢紊乱与炎症和动脉粥样硬化发展之间的联系机制仍有待阐明。我们发表的工作和初步数据表明,双链 RNA 激活蛋白激酶 PKR 在肥胖背景下被激活,在驱动炎症和葡萄糖稳态恶化方面发挥着关键作用。在巨噬细胞中,暴露于脂毒性信号和脂蛋白会激活 PKR。此外,PKR 是激活 NLRP3 炎性体和 JNK 等应激信号通路的关键组成部分,这些通路与糖尿病和动脉粥样硬化的发病机制有关。此外,在支持本提案中提出的数据中,我们证明了对 PKR 缺陷小鼠中动脉粥样硬化斑块发展的显着保护作用。基于这些发现,我们的总体假设是,通过调节炎症活动、胰岛素作用和蛋白质合成,PKR 将细胞应激和代谢信号与慢性炎症和动脉粥样硬化联系起来。本提案中描述的实验将通过确定 PKR 在巨噬细胞激活和功能中的作用,并通过评估全身和巨噬细胞在体内动脉粥样硬化发展中对 PKR 的特异性需求来检验该假设。这一贡献将扩大我们对营养应激与心脏代谢疾病发展之间联系的理解。这项工作的创新之处在于通过确定血脂异常和免疫细胞炎症激活之间的机制联系来研究动脉粥样硬化治疗的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GOKHAN S HOTAMISLIGIL其他文献

GOKHAN S HOTAMISLIGIL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GOKHAN S HOTAMISLIGIL', 18)}}的其他基金

Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
脂肪因子 FABP4 在血糖调节和反调节反应中的作用
  • 批准号:
    10530591
  • 财政年份:
    2019
  • 资助金额:
    $ 40.38万
  • 项目类别:
Novel pathways controlling macrophage inflammation and resolution in atherosclerosis
控制巨噬细胞炎症和动脉粥样硬化消退的新途径
  • 批准号:
    10216329
  • 财政年份:
    2019
  • 资助金额:
    $ 40.38万
  • 项目类别:
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
脂肪因子 FABP4 在血糖调节和反调节反应中的作用
  • 批准号:
    10304199
  • 财政年份:
    2019
  • 资助金额:
    $ 40.38万
  • 项目类别:
Novel pathways controlling macrophage inflammation and resolution in atherosclerosis
控制巨噬细胞炎症和动脉粥样硬化消退的新途径
  • 批准号:
    10450684
  • 财政年份:
    2019
  • 资助金额:
    $ 40.38万
  • 项目类别:
The role of immunometabolic pathways in atherosclerosis
免疫代谢途径在动脉粥样硬化中的作用
  • 批准号:
    9171375
  • 财政年份:
    2014
  • 资助金额:
    $ 40.38万
  • 项目类别:
Deconvolution of adaptive metabolic responses of the endoplasmic reticulum
内质网适应性代谢反应的反卷积
  • 批准号:
    8047403
  • 财政年份:
    2010
  • 资助金额:
    $ 40.38万
  • 项目类别:
Lipids, Inflammation and Insulin Action
脂质、炎症和胰岛素作用
  • 批准号:
    7996838
  • 财政年份:
    2009
  • 资助金额:
    $ 40.38万
  • 项目类别:
Lipids, Inflammation and Insulin Action
脂质、炎症和胰岛素作用
  • 批准号:
    8409824
  • 财政年份:
    2004
  • 资助金额:
    $ 40.38万
  • 项目类别:
Lipids, Inflammation and Insulin Action
脂质、炎症和胰岛素作用
  • 批准号:
    7583753
  • 财政年份:
    2004
  • 资助金额:
    $ 40.38万
  • 项目类别:
Lipids, Inflammation and Insulin Action
脂质、炎症和胰岛素作用
  • 批准号:
    6827062
  • 财政年份:
    2004
  • 资助金额:
    $ 40.38万
  • 项目类别:

相似海外基金

Quantification of atherosclerosis by movies of carotid arteries for early detection of atherosclerosis
通过颈动脉影像量化动脉粥样硬化,以早期发现动脉粥样硬化
  • 批准号:
    16K08965
  • 财政年份:
    2016
  • 资助金额:
    $ 40.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of mechanism of atherosclerosis focusing on arteries, microvessels in perivascular tissues and vasa vasorum in adventitia
以动脉、血管周围组织中的微血管和外膜中的滋养管阐明动脉粥样硬化的机制
  • 批准号:
    26461141
  • 财政年份:
    2014
  • 资助金额:
    $ 40.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DIAGNOSIS OF ATHEROSCLEROSIS IN MUSCULAR ARTERIES USING NIR RAMAN SPECTROSCOPY
使用近红外拉曼光谱诊断肌动脉粥样硬化
  • 批准号:
    6615287
  • 财政年份:
    2002
  • 资助金额:
    $ 40.38万
  • 项目类别:
DIAGNOSIS OF ATHEROSCLEROSIS IN MUSCULAR ARTERIES USING NIR RAMAN SPECTROSCOPY
使用近红外拉曼光谱诊断肌动脉粥样硬化
  • 批准号:
    6314196
  • 财政年份:
    2000
  • 资助金额:
    $ 40.38万
  • 项目类别:
DIAGNOSIS OF ATHEROSCLEROSIS IN MUSCULAR ARTERIES USING NIR RAMAN SPECTROSCOPY
使用近红外拉曼光谱诊断肌动脉粥样硬化
  • 批准号:
    6121244
  • 财政年份:
    1999
  • 资助金额:
    $ 40.38万
  • 项目类别:
DIAGNOSIS OF ATHEROSCLEROSIS IN MUSCULAR ARTERIES USING NIR RAMAN SPECTROSCOPY
使用近红外拉曼光谱诊断肌动脉粥样硬化
  • 批准号:
    6281785
  • 财政年份:
    1998
  • 资助金额:
    $ 40.38万
  • 项目类别:
DIAGNOSIS OF ATHEROSCLEROSIS IN MUSCULAR ARTERIES: NEAR INFRARED RAMAN SPECT
肌动脉粥样硬化的诊断:近红外拉曼光谱
  • 批准号:
    6252359
  • 财政年份:
    1997
  • 资助金额:
    $ 40.38万
  • 项目类别:
A Historical Study on Atherosclerosis WHHL Rabbit with Reference to Carotid Arteries and Intracranial Arteries
WHHL兔颈动脉和颅内动脉动脉粥样硬化的历史研究
  • 批准号:
    63570689
  • 财政年份:
    1989
  • 资助金额:
    $ 40.38万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Pulsatile Flow and the Susceptibility of Arteries to Atherosclerosis
脉动血流和动脉对动脉粥样硬化的易感性
  • 批准号:
    8416361
  • 财政年份:
    1985
  • 资助金额:
    $ 40.38万
  • 项目类别:
    Continuing Grant
DIAGNOSIS OF ATHEROSCLEROSIS IN MUSCULAR ARTERIES USING NEAR INFRARED RAMAN
使用近红外拉曼诊断肌动脉粥样硬化
  • 批准号:
    5224224
  • 财政年份:
  • 资助金额:
    $ 40.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了